BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9534235)

  • 1. Re-evaluation of the serotypes of Serratia marcescens and separation into two schemes based on lipopolysaccharide (O) and capsular polysaccharide (K) antigens.
    Aucken HM; Wilkinson SG; Pitt TL
    Microbiology (Reading); 1998 Mar; 144 ( Pt 3)():639-653. PubMed ID: 9534235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of two new O serotypes of Serratia marcescens (O27 and O28).
    Aucken HM; Wilkinson SG; Pitt TL
    FEMS Microbiol Lett; 1996 Apr; 138(1):77-82. PubMed ID: 8674974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and serological studies of lipopolysaccharides from proposed new serotypes (O25 and O26) of Serratia marcescens.
    Aucken HM; Merkouroglou M; Miller AW; Galbraith L; Wilkinson SG
    FEMS Microbiol Lett; 1995 Aug; 130(2-3):267-72. PubMed ID: 7544311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of capsular antigens in Serratia marcescens.
    Aucken HM; Wilkinson SG; Pitt TL
    J Clin Microbiol; 1997 Jan; 35(1):59-63. PubMed ID: 8968881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1097-104. PubMed ID: 9856646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-antigen specificities of the serotype strains of Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2697-701. PubMed ID: 2480361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a neutral glycan from the lipopolysaccharides of reference strains for Serratia marcescens serogroups O2 and O3.
    Oxley D; Wilkinson SG
    FEMS Microbiol Lett; 1992 Dec; 78(2-3):209-12. PubMed ID: 1283379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the acidic microcapsular glycan from the reference strain (C.D.C. 6320-58) for Serratia marcescens serotype O14:K12.
    Eserstam R; Slater C; Jansson PE; Widmalm G; Rundlöf T; Wilkinson SG
    Carbohydr Res; 2000 Oct; 329(1):227-32. PubMed ID: 11086704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of an acidic microcapsular glycan from the reference strain (C.D.C. 866-57) for Serratia marcescens serogroup O1.
    Johansson A; Widmalm G; Jansson PE; Wilkinson SG
    Carbohydr Res; 1995 Apr; 270(2):191-9. PubMed ID: 7585699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological relationships of the O antigens of Klebsiella pneumoniae O5, Escherichia coli O8 and a new O serotype of Serratia marcescens.
    Aucken HM; Pitt TL
    FEMS Microbiol Lett; 1991 May; 64(1):93-7. PubMed ID: 1713181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved O-serotyping method for Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2702-5. PubMed ID: 2480362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between rfb gene clusters required for biosynthesis of identical D-galactose-containing O antigens in Klebsiella pneumoniae serotype O1 and Serratia marcescens serotype O16.
    Szabo M; Bronner D; Whitfield C
    J Bacteriol; 1995 Mar; 177(6):1544-53. PubMed ID: 7533758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antigenic lipopolysaccharide O chain and the capsular polysaccharide produced by Actinobacillus pleuropneumoniae serotype 13.
    MacLean LL; Perry MB; Vinogradov E
    Infect Immun; 2004 Oct; 72(10):5925-30. PubMed ID: 15385495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of a fructosylated capsule polysaccharide and sialylated lipopolysaccharide in a virulent strain of Actinobacillus suis.
    Deutschmann R; Boncheff AG; MacInnes JI; Monteiro MA
    Biochem Cell Biol; 2011 Jun; 89(3):325-31. PubMed ID: 21612441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens.
    Sims TJ; Schifferle RE; Ali RW; Skaug N; Page RC
    Oral Microbiol Immunol; 2001 Aug; 16(4):193-201. PubMed ID: 11442843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the lipopolysaccharide O antigens of Actinobacillus pleuropneumoniae serotypes 9 and 11: antigenic relationships among serotypes 9, 11, and 1.
    Beynon LM; Griffith DW; Richards JC; Perry MB
    J Bacteriol; 1992 Aug; 174(16):5324-31. PubMed ID: 1379584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
    Aucken HM; Pitt TL
    J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the O-specific galactan from the lipopolysaccharide of the reference strain for Serratia marcescens serogroup O24.
    Oxley D; Wilkinson SG
    Carbohydr Res; 1989 Dec; 195(1):117-22. PubMed ID: 2699831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of an acidic glycan present in the lipopolysaccharide extract from the reference strain for Serratia marcescens serogroup O18.
    Oxley D; Wilkinson SG
    Carbohydr Res; 1991 Aug; 215(2):293-301. PubMed ID: 1794127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a glucorhamnan from the lipopolysaccharide of Serratia marcescens strain S1254.
    Oxley D; Wilkinson SG
    Carbohydr Res; 1991 Jan; 209():319-22. PubMed ID: 1709820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.